Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Description
CLP 290 is a K+/Cl- Cotransporter 2 (KCC2) activator. Activates spinal inhibitory interneurons, restores physiological neuronal activity in the spinal cord and induces functional recovery in a mouse model of spinal cord injury. Also decreases blood vasopressin and glucose levels in mice with Streptozotocin (Cat. No. 1621) induced diabetes mellitus. Orally bioavailable prodrug of CLP 257 (Cat. No.5242).
Greener Choice Claims
- Environmental benefits include:
- Ozone-Safe or Safe for the Ozone Layer
Specifications
Specifications
Chemical Name or Material | (Z)-5-Fluoro-2-((4-oxo-2-(tetrahydropyridazin-1(2 H)-yl)thiazol-5(4 H)-ylidene)methyl)phenyl pyrrolidine-1-carboxylate |
CAS | 1181083-81-7 |
Quantity | 50 mg |
Target | KCC2 Activators |
Molecular Formula | C19H21FN4O3S |
Formula Weight | 7828 |
Purity | 98% |
Product Suggestions
Customers who viewed this item also viewed
Viewing 1-5 of 7
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Tocris™ CLP 290 >
Spot an opportunity for improvement?Share a Content Correction